Acetyl Gastric Inhibitory Peptide (human) carries an N-terminal acetyl group that enhances resistance to exopeptidases and modulates overall charge. The modification maintains the native core sequence for receptor-interaction research. Researchers employ this peptide in structural and biophysical analyses of GIP. Its stabilized backbone supports extended in vitro studies of peptide behavior.
CAT No: G02011
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More